1 |
Presley C, Lilenbaum R. The Treatment of Advanced Lung Cancer in the Elderly : The Role of a Comprehensive Geriatric Assessment and Doublet Chemotherapy. Cancer J 2015;21(5):392-7.
DOI
|
2 |
Hurria A. Management of elderly patients with cancer. J Natl Compr Canc Netw 2013;11:698-701.
DOI
|
3 |
Park SY. Safety and efficacy of adjuvant therapy after surgery of elderly colon cancer patients 70 years of age or older. Master's thesis, Dept. of Medicine, Chung-Ang University 2015.
|
4 |
Shin GY. Study on current use of chemotherapy in elderly patients with colorectal cancer. Master's thesis, Dept. of Clinical Health Science, Ewha Womans University 2012.
|
5 |
Lee JS, Cho MR, Lee GJ. Validation of the developed nutritional screening tool for hospital patients. Korean J Nutr 2010;43(2):189-96.
DOI
|
6 |
Jatoi A, Foster NR, Egner JR, Burch PA, Stella PJ, Rubin J, et al. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophagealjunction, and stomach : a pooled analysis of eight consecutive North Central Cancer Treatment Group(NCCTG) trials. Int J Oncol 2010;36:601-6.
|
7 |
Saif MW, Lichtman SM. Chemotherapy options and outcomes in older adult patients with colorectal cancer. Crit Rev Oncol Hematol 2009;72:155-69.
DOI
|
8 |
de Kock I, Mirhosseini M, Lau F, Thai V, Downing M, Quan H, et al. Conversion of Karnofsky Performance Status(KPS) and Eastern Cooperative Oncology Group Performance Status(ECOG) to Palliative Performance Scale(PPS), and the interchangeability of PPS and KPS in prognostic tools. J Palliat Care 2013;29(3):163-9.
|
9 |
Ommundsen N, Wyller TB, Nesbakken A, Jordhøy MS, Bakka A, Skovlund E, et al. Frailty is an independent predictor of survival in older patients with colorectal cancer. Oncologist 2014;19(12):1268-75.
DOI
|
10 |
Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005;23:6240-8.
DOI
|
11 |
Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends 2015;9(1):16-34.
DOI
|
12 |
Folprecht G, Seymour MT, Saltz L, Douillard JY, Hecker H, Stephens RJ, et al. Irinotecan/Fuorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials. J Clin Oncol 2008;26(9):1443-51.
DOI
|
13 |
United States Census: U.S. Census Bureau projections show a slower growing, older, more diverse nation a half century from now. Available form: http://www.census.gov/newsroom/releases/archives/population/cb12-243.html
|
14 |
National Cancer Information Center. Available form: http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040401000000
|
15 |
Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341(27):2061-7.
DOI
|
16 |
Miguchi M, Shimomura M, Hinoi T, Egi H, Ohdan H. Chemotherapeutic outcomes for metastatic colorectal cancer in elderly patients aged≥75 years: A single-institutional retrospective analysis. Asia Pac J Clin Oncol 2016;12(2):151-8.
DOI
|
17 |
Malfuson JV, Etienne A, Turlure P, de Revel T, Thomas X, Contentin N, et al. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia. Haematologica 2008;93(12):1806-13.
DOI
|
18 |
Hamaker ME, Seynaeve C, Wymenga AN, van Tinteren H, Nortier JW, Maartense E, et al. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists’ Group. Breast 2014;23(1):81-7.
DOI
|